Related references
Note: Only part of the references are listed.Nox and renal disease
Chet E. Holterman et al.
CLINICAL SCIENCE (2015)
Intermedin is upregulated and attenuates renal fibrosis by inhibition of oxidative stress in rats with unilateral ureteral obstruction
Xi Qiao et al.
NEPHROLOGY (2015)
EW-7197 inhibits hepatic, renal, and pulmonary fibrosis by blocking TGF-β/Smad and ROS signaling
Sang-A Park et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development
Hyun Mi Kang et al.
NATURE MEDICINE (2015)
Cost-effectiveness of Primary Screening for CKD: A Systematic Review
Paul Komenda et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
Cellular and molecular mechanisms in kidney fibrosis
Jeremy S. Duffield
JOURNAL OF CLINICAL INVESTIGATION (2014)
Genetic Targeting or Pharmacologic Inhibition of NADPH Oxidase Nox4 Provides Renoprotection in Long-Term Diabetic Nephropathy
Jay C. Jha et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Mammalian Target of Rapamycin Regulates Nox4-Mediated Podocyte Depletion in Diabetic Renal Injury
Assaad A. Eid et al.
DIABETES (2013)
Nox4 and diabetic nephropathy: With a friend like this, who needs enemies?
Yves Gorin et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Pathogenesis of Chronic Cardiorenal Syndrome: Is There a Role for Oxidative Stress?
Speranza Rubattu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
NADPH Oxidases, Reactive Oxygen Species, and the Kidney: Friend and Foe
Mona Sedeek et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Intermedin/adrenomedullin 2 protects against tubular cell hypoxia-reoxygenation injury in vitro by promoting cell proliferation and upregulating cyclin D1 expression
Yanhong Wang et al.
NEPHROLOGY (2013)
Intermedin enhances sympathetic outflow via receptor-mediated cAMP/PKA signaling pathway in nucleus tractus solitarii of rats
Peng Li et al.
PEPTIDES (2013)
Intermedin protects against renal ischemia-reperfusion injury by inhibition of oxidative stress
Xi Qiao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2013)
ADAM17 mediates Nox4 expression and NADPH oxidase activity in the kidney cortex of OVE26 mice
Bridget M. Ford et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2013)
Intermedin (adrenomedullin2) stabilizes the endothelial barrier and antagonizes thrombin-induced barrier failure in endothelial cell monolayers
M. Aslam et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Targeting NADPH oxidases in vascular pharmacology
Agata Schramm et al.
VASCULAR PHARMACOLOGY (2012)
Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases
Jeffrey L. Barnes et al.
KIDNEY INTERNATIONAL (2011)
AMP-activated Protein Kinase (AMPK) Negatively Regulates Nox4-dependent Activation of p53 and Epithelial Cell Apoptosis in Diabetes
Assaad A. Eid et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy
M. Sedeek et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Adrenomedullin inhibits angiotensin II-induced oxidative stress and gene expression in rat endothelial cells
Takanobu Yoshimoto et al.
HYPERTENSION RESEARCH (2005)
Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes
J Roh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
A novel superoxide-producing NAD(P)H oxidase in kidney
A Shiose et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Identification of Renox, an NAD(P)H oxidase in kidney
M Geiszt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
